A Study of Proteins C and S in Patients with Prostatic Disease

Thromb Haemost 1988; 60(01): 122
DOI: 10.1055/s-0038-1647648

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Benjamin Esparaz

Northwestern University Medical School, 345 East Superior Street Chicago, Illinois 60611, USA
David Green

Northwestern University Medical School, 345 East Superior Street Chicago, Illinois 60611, USA

References
1 Rapaport SI, Chapman CG. Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. Am J Med 1959; 27: 144-153
2 Pineo GF, Brain MC, Gallus AS. Tumors, mucus production and hypercoagulability. Ann NYA. cad Sci 1974; 230: 262-270
3 Bick RL. Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management. Semin Thromb Haemostas 1978; 5: 1-6
4 Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186
5 Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987; 69: 692-694
6 Green D, Ganger DR, Blei AT. Protein C deficiency in splanchnic venous thrombosis. Am J Med 1987; 82: 1171-1174